Tuesday, March 12, 2013

Optogenetic Technology Gets Patent Notice of Allowance

“Technology to restore vision through the use of a component of green algae developed by Dr. Zhou-Han Pan, professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute at Wayne State University, and licensed to RetroSense Therapeutics” has received a Notice of Allowance for U.S. patent application (No. 12/299,574) from the U.S. Patent and Trademark Office, according to a post on Medical News Today. “The notice broadly covers methods of restoring visual responses with a variety of optogenetic compounds.” Read more.

No comments:

Post a Comment

Post a Comment